The effects of L-Arginine supplementation on growth performance and intestinal health of broiler chickens challenged with Eimeria spp.

This study evaluated the effects of varying levels of L-arginine (Arg) on performance and intestinal health of broilers challenged with Eimeria. Cobb 500 male chicks (n = 720) were randomly distributed in a 5 × 2 factorial arrangement (6 replicates/12 birds). The main factors were Arg levels (1.04, 1.14, 1.24, 1.34, 1.44%) and challenge or non-challenge with Eimeria. At day 12, in the challenge group, each bird received orally 12,500 Eimeria maxima, 12,500 Eimeria tenella, and 62,500 Eimeria acervulina sporulated oocysts. At 5 d postinfection (dpi), intestinal permeability was measured. At 6 and 14 dpi, performance, intestinal histomorphology, nutrient digestibility, tight junction protein (TJP) gene expression, and antioxidant markers were evaluated. Few interactions were found, and when significant, the supplementation of Arg did not counteract the negative effects of Eimeria challenge. Challenge, regardless of Arg level, increased intestinal permeability, although the expression of Claudin-1, a TJP, was upregulated. At 6 dpi, the antioxidant system was impaired by the challenge. Moreover, growth performance, intestinal histomorphology, and nutrient digestibility were negatively affected by challenge at 6 and 14 dpi. Regardless of challenge, from 0 to 14 dpi, birds fed 1.44% showed higher weight gain than 1.04% of Arg, and birds fed 1.34% showed lower feed conversion than 1.04% of Arg. At 5 dpi, intestinal permeability was improved in birds fed 1.34% than 1.04% of Arg. Moreover, 1.34% of Arg upregulated the expression of the TJP Zonula occludens-1 (ZO-1) as compared with 1.24 and 1.44% of Arg at 6 dpi. At 14 dpi, 1.44% of Arg upregulated the expression of ZO-1 and ZO-2 compared with 1.24 and 1.34% of Arg. The nutrient digestibility was quadratically influenced by Arg, whereas the antioxidant markers were unaffected. Thus, the challenge with Eimeria had a negative impact on growth and intestinal health. The dietary supplementation of levels ranging from 1.24 to 1.44% of Arg showed promising results, improving overall growth, intestinal integrity, and morphology in broilers subjected or not to Eimeria challenge.

Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome.

Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.

Performance and bone quality of broilers fed diets containing different levels of phosphorus and supplemented with phytase / Rendimiento y calidad ósea de pollos de engorde alimentados con dietas que contienen diferentes niveles de fósforo y suplementadas con fitasa / Desempenho e qualidade óssea de frangos de corte alimentados com dietas com diferentes níveis de fósforo e suplementadas com fitase

Abstract Background: Although phytase has been widely used in poultry nutrition, the effects of the enzyme on broilers fed low levels of phosphorus are poorly understood. Objective: To evaluate the effects of two commercial phytases on live performance and bone quality of broilers fed diets with normal and reduced levels of phosphorus. Methods: Two experiments were conducted with four treatments and six repetitions with 30 birds each, for a total of 24 groups. The first experiment (Exp. I) used a reference level of available phosphorus (AP) with four treatments, as follows: Positive control= 0.45% AP starter diet/0.40% AP grower diet without phytase; Phytase X= 0.35% AP starter diet/0.30% AP grower diet + Phytase X; Phytase Y= 0.35% AP starter diet/0.30% AP grower diet + Phytase Y; and Negative control= 0.35% AP starter diet/0.30% AP grower diet, without phytase. In experiment II (Exp. II) the same treatments were used, but AP levels were reduced by 0.10%. The variables analyzed were: performance from one to 35 days, and bone quality at 35 days of age. Both experiments were analyzed using a completely randomized design. Results: In Exp. I, the positive control resulted in greater body weight gain (2,558 g; p<0,05) compared to Phytase Y (2,470 g) and negative control (2,472 g), and better feed conversion ratio (1.48; p<0,05) than the negative control (1.51). However, when phosphorus was reduced in Exp. II, the positive control and treatments with Phytase X showed better results (p<0.01) for feed intake (3,608 g and 3,593 g, respectively) and weight gain (2,430 g and 2,400 g, respectively) compared to the negative control (2,889 g of feed intake and 1,915 g of weight gain; p<0.01), which also presented low bone ash (36.8%) and phosphorus in the tibia (5.48%; p<0.01). Conclusion: Reducing AP concentration in diets not added with phytase negatively affects weight gain and feed intake of broilers.

Resumen Antecedentes: Aunque la fitasa ha sido ampliamente utilizada en nutrición aviar, sus efectos en pollos de engorde alimentados con bajos niveles de fósforo son poco comprendidos. Objetivo: Evaluar el efecto de dos fitasas comerciales sobre el desempeño y la calidad ósea de pollos de engorde alimentados con dietas con niveles normales y reducidos de fósforo. Métodos: Se realizaron dos experimentos con cuatro tratamientos y seis repeticiones de 30 aves cada una, totalizando 24 grupos. En el primero (Exp. I) se utilizó el nivel de referencia de fósforo disponible (Pd) con cuatro tratamientos, así: Control positivo= 0,45% Pd dieta inicial/0,40% Pd dieta de engorde, sin fitasa; Fitasa X= 0,35% Pd dieta inicial/0,30% Pd dieta engorde + Fitasa X; Fitasa Y= 0,35% Pd dieta inicial/0,30% Pd dieta engorde + Fitasa Y; finalmente, Control negativo= 0,35% Pd dieta inicial/0,30% Pd dieta engorde, sin fitasa. En el segundo experimento (Exp. II) se utilizaron los mismos tratamientos, pero reduciendo en 0,10% el nivel de Pd. Las variables analizadas fueron: desempeño de uno a siete días y de uno a 35 días y calidad ósea a los 35 días de edad. Ambos experimentos se analizaron mediante un diseño completamente aleatorizado. Resultados: En el Exp. I, control positivo presentó una mayor ganancia de peso corporal (2.558 g; p<0,05) en comparación con la Fitasa Y (2.470 g) y el control negativo (2.472 g), y mejor índice de conversión alimenticia (1,48; p<0,05) que el control negativo (1,51). Sin embargo, cuando se redujo el nivel de fósforo en el Exp. II, el control positivo y los tratamientos con Fitasa X mostraron mejores resultados (p<0,01) para el consumo de alimento (3.608 g y 3.593 g, respectivamente) y la ganancia de peso (2.430 g y 2.400 g, respectivamente) en comparación con el control negativo (2.889 g de consumo de alimento y 1.915 g de ganancia de peso; p<0,01), el cual también presentó baja concentración de cenizas óseas (36,8%) y fósforo en tibia (5,48%; p<0,01). Conclusión: La reducción de la concentración de Pd en dietas no aditivadas con fitasa afecta negativamente la ganancia de peso y el consumo de alimento del pollo de engorde.

Resumo Antecedentes: A fitase é uma enzima amplamente utilizada na nutrição de frangos de corte. No entanto existem várias opções comerciais e seus efeitos com níveis reduzidos de fósforo, são pouco avaliados. Objetivo: Avaliar o efeito da suplementação de fitases comerciais no desempenho e na qualidade óssea de frangos de corte, alimentados com níveis normais e reduzidos de fósforo. Métodos: Dois experimentos foram conduzidos com quatro tratamentos e seis repetições, com 30 aves em cada, totalizando 24 grupos. No primeiro (I) utilizou o nível de referência de fósforo disponível (Pd), totalizando quatro tratamentos: controle positivo= 0,45% Pd dieta inicial/0,40% Pd dieta crescimento, sem fitase; tratamento fitase X= 0,35% Pd dieta inicial/0,30% Pd dieta crescimento + Fitase X; tratamento fitase Y= 0,35% Pd dieta inicial/0,30% Pd dieta de crescimento + Fitase Y; e controle negativo 0,35% Pd dieta inicial/0,30% Pd dieta crescimento, sem fitase. O segundo experimento utilizou os mesmos tratamentos, reduzindo 0,10% o nível de Pd. As variáveis ​​analisadas foram: desempenho de um a sete dias e de sete a 35 dias e qualidade óssea aos 35 dias. Ambos os experimentos foram analisados usando um delineamento inteiramente casualizado. Resultados: No Experimento I, o tratamento controle positivo apresentou maior ganho de peso corporal (2.557,86 g; p<0,05) em relação a fitase Y (2.470,27 g) e o controle negativo (2.471,73 g) e melhor índice de conversão alimentar (1,48; p<0,05) do que o tratamento controle negativo (1,51). Porém, quando o nível de fósforo foi reduzido no Experimento II, o controle positivo e os tratamentos com fitase X apresentaram os melhores resultados (p<0,01) para consumo de ração (3.608,0 g e 3.593,1 g, respectivamente) e ganho de peso corporal (2.429,8 g e 2.399,9 g, respectivamente) em comparação ao tratamento controle negativo (2.889,0 g de ingestão de ração e 1.915,3 g de ganho de peso corporal; p<0,01) que também apresentou baixa concentração de cinzas ósseas (36,8%) e fósforo na tíbia (5,48%; p<0,01). Conclusões. A redução da concentração de AP sem o uso de fitase reduz o ganho de peso corporal e o consumo de ração de frangos de corte.

Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome

Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.

Molecular alterations in the extracellular matrix in the brains of newborns with congenital Zika syndrome

Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.

Variants of the recently discovered avian gyrovirus 2 are detected in Southern Brazil and The Netherlands.

A genome of a virus preliminarily named avian gyrovirus 2 (AGV2), a close relative to chicken anemia virus, was recently discovered in a chicken in the state of Rio Grande do Sul, Southern Brazil. To study the occurrence of AGV2 in Rio Grande do Sul and the neighboring state Santa Catarina, a number of adult chickens (n=108 and n=48, respectively) were tested for the presence of AGV2 DNA. An AGV2-specific PCR was developed, optimized and used to analyze DNA extracted from clinical samples. AGV2 DNA was detected in 98/108 (90.7%) of samples collected in the state of Rio Grande do Sul and 29/48 (60.4%) of the samples collected in the state of Santa Catarina. In order to check whether AGV2 DNA would be detected in samples from a geographically distant region, DNA from brain samples of 21 diseased chickens from the Netherlands were tested independently, by the same method. In such specimens, 9/21 (42.9%) brain tissue samples were found to contain AVG2 DNA. Sequence analysis of some of the PCR products demonstrated that the amplified AGV2 sequences could vary up to 15.8% and could preliminarily be divided in three groups. This indicated the occurrence of variants of AGV2, which may reflect differences in geographical origin and/or in biological properties. The data presented here provides evidence that AGV2 seems fairly distributed in chickens in Southern Brazil and that AGV2 also circulates in the Netherlands. Besides, circulating viruses display genetic variants whose significance should be further examined, particularly to determine whether AGV2 would play any role in chicken diseases.